Key result
ACE D/D and ACE2 G/G genotypes linked to greater COVID-19 severity.
Why the study?
The renin-angiotensin system plays a role in COVID-19 genesis, and numerous genetic factors influence susceptibility and disease severity.
Do ACE I/D and ACE2 rs2285666 polymorphisms associate with disease severity in patients with COVID-19?
Observational (n=300)
Do ACE I/D and ACE2 rs2285666 polymorphisms associate with disease severity in patients with COVID-19?
The homozygous ACE D/D genotype and the ACE2 G/G genotype are associated with an increased susceptibility to severe COVID-19.
Answers are grounded in this paper and cite their sources.
ACE I/D genotyping should not guide COVID-19 care; leaves open its prognostic value pending validation.
Background: Numerous genetic factors influence the severity and susceptibility to COVID-19. The renin-angiotensin system has a role in the genesis of COVID-19. This study aims to investigate the genetic polymorphisms of Angiotensin-Converting Enzyme Insertion/Deletion (ACE I/D) and ACE2 rs2285666 in patients with COVID-19 and their association with mild, severe, and critical disease symptoms. Materials and Methods: This study included 300 patients with COVID-19, categorized as mild, severe, and critical. Genotypes for the I/D polymorphism of ACE1 and the rs2285666 polymorphism of ACE2 were determined in all samples using polymerase chain reaction (PCR) and restriction fragment length polymorphism-PCR methodologies, respectively. Results: This study revealed a significant association between the ACEI/D genotype and the severity of COVID-19 ( p < 0.001). A strong association was seen between the frequency of ACEI/D alleles and the severity of COVID-19, with the D allele being more prevalent in the severe and critical cohorts compared with the mild cohort ( p < 0.001). A significant association was found between the ACE2 rs2285666 polymorphism and disease severity in both male and female groups ( p < 0.05). The frequency of G/A alleles linked to the ACE2 polymorphism exhibited a significant association with disease severity, as the G allele was more common in the severe and critical groups than in the mild group ( p = 0.004). Conclusion: Individuals with the homozygous ACE D/D genotype have an increased susceptibility to severe COVID-19, while the presence of allele I may provide a preventive advantage against severe disease symptoms. The ACE2 rs2285666 variant is associated with disease severity, while the ACE2 G/G genotype is linked to an increased severity of COVID-19.
No takes yet. Share an insight, caveat, or question.
Drikvand et al. (2025) conducted an observational in COVID-19 (n=300). ACE I/D and ACE2 rs2285666 polymorphisms vs. Alternative genotypes was evaluated on COVID-19 disease severity (p=< 0.001). The ACE D/D genotype and ACE2 G/G genotype are associated with increased COVID-19 severity.
Synapse has enriched 10 related papers. Consider them for comparative context: